GERMS · 2021 · 21 citations · 9 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial ResistanceAntimicrobial StewardshipBacteriologyAntibacterial ResistanceAntibiotic ResistanceAntimicrobial Susceptibility TestingBacterial InfectionsHospital Antimicrobial StewardshipResistance SurveillanceAntibiotic Susceptibility TestingHospital Antimicrobial Resistance SurveillancePhenotypic Bacterial IdentificationPhenotypic Characterization Of IsolatesPseudomonas Aeruginosa ResistancePseudomonas FluorescensPseudomonas SpeciesSurveillance Of Resistant Isolates
Introduction: Pseudomonads constitute critical agents of opportunistic infections in hospital settings particularly in immunocompromised patients and Pseudomonas aeruginosa is a major flagship member of these infectious agents. This study assessed the distribution of Pseudomonas spp. associated with infections in patients and their antibiotic resistance patterns as part of an antibiotic stewardship intervention program and resistance surveillance. Methods: One hundred and fifty Pseudomonas spp. from different clinical specimens were obtained from the Obafemi Awolowo University Teaching Hospitals Complex Ile-Ife. Culture was carried out on MacConkey and blood agar while phenotypic characterization was done by Gram staining, oxidase, and catalase test. Species identification was done using MICROBACTTM 24E bacterial identification kit and confirmed by 16S rDNA polymerase chain reaction (PCR) assay. Antibiotic susceptibility testing to eight antibiotics in four classes was done. Results: Pseudomonas aeruginosa was the most frequently occurring species (96.0%); P. putida (2.67%) and P. fluorescens (0.67%) were also identified as well as an isolate of Burkholderia pseudomallei (0.67%). The highest resistance rate among isolates was observed towards gentamicin (35.4%); piperacillin/tazobactam was the most active antibiotic. Multidrug-resistant (MDR) strains constituted 12.8% of the isolates and most MDR strains also displayed a high multiple antibiotic resistance index (MAR). Conclusions: Pseudomonas aeruginosa is emerging as a highly MDR pathogen in our hospital setting. This calls for the establishment of a surveillance system and antimicrobial stewardship programme in place. Furthermore, we propose a review of the current antibiotics prescription policy, and infection control programmes (ICPs) if we must control the spread of MDR-P. aeruginosa in this environment.
9
Anna-Pelagia Magiorakos, Arjun Srinivasan, Roberta B. Carey et al. · Clinical Microbiology and Infection · 2011 · 14K citations
Theodore Spilker, Tom Coenye, Peter Vandamme et al. · Journal of Clinical Microbiology · 2004 · 492 citations · Full text
Gamal F. M. Gad, Ramadan A. El-Domany, Sahar Zaki et al. · Journal of Antimicrobial Chemotherapy · 2007 · 143 citations · Full text
Silke Peter, Philipp Oberhettinger, Leonard Schuele et al. · BMC Genomics · 2017 · 66 citations · Full text